Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Toripalimab and chemotherapy in tracheal squamous cell carcinoma
NCT04716751Phase 2Unknown
- Sponsor
- Shanghai Pulmonary Hospital
- Start
- Feb 2021
- Primary completion
- Jan 2022
01
Overview
A Phase 2 trial of toripalimab in Tracheal squamous cell carcinoma (TSCC), sponsored by Shanghai Pulmonary Hospital. Status: unknown.
02
Drugs
toripalimab
03
Conditions
Tracheal squamous cell carcinoma (TSCC)
Beyond the preview
Go deeper on NCT04716751.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04716751.